Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens

BACKGROUND: The highly attenuated vaccinia virus strain NYVAC expressing HIV-1 components has been evaluated as a vaccine candidate in preclinical and clinical trials with encouraging results. We have previously described that the presence of C7L in the NYVAC genome prevents the induction of apoptos...

Descripción completa

Detalles Bibliográficos
Autores principales: Nájera, José Luis, Gómez, Carmen Elena, García-Arriaza, Juan, Sorzano, Carlos Oscar, Esteban, Mariano
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894869/
https://www.ncbi.nlm.nih.gov/pubmed/20613977
http://dx.doi.org/10.1371/journal.pone.0011406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894869/
https://www.ncbi.nlm.nih.gov/pubmed/20613977
http://dx.doi.org/10.1371/journal.pone.0011406

Ejemplares similares